Metraipolis › archive › dc_835c8676c643

Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41907591
DOI
10.3389/fonc.2026.1713930
License (as archived)
solo-consultazione
Archived
2026-11-04T11:26:20.380Z
SHA-256 of the archived text
ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47
Stable URL of this page
https://metraipolis.com/documento/dc_835c8676c643

How to cite

Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591 — Europe PMC (en), https://europepmc.org/article/MED/41907591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_835c8676c643 (Metraipolis archive dc_835c8676c643, sha256 ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47)
BibTeX
@misc{dc835c8676c643,
  title = {Differences in residual lesion detection after treatment of metastatic prostate cancer based on dual-tracer PET/CT — Europe PMC PMID:41907591},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41907591},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_835c8676c643; sha256 ff309c878d2759274e5969bdf65f0c5da46647e19132a287fa7d4e7ca4547c47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907591. Agents can read the archived copy with the MCP tool read_document.